March 17, 2025 - 22:35
A recent study conducted by Emily Hackworth, a 2024 graduate from the Arnold School's Ph.D. program in Health Promotion, Education, and Behavior, reveals a concerning trend among youth aged 16 to 19. The research indicates that individuals experiencing internalizing mental health symptoms—such as anxiety, depression, sadness, and loneliness—are significantly more likely to use nicotine products, especially electronic cigarettes, compared to their peers who do not exhibit these symptoms.
The findings suggest a troubling intersection between mental health challenges and substance use among adolescents. As mental health issues become increasingly prevalent in this age group, understanding the factors that drive youth toward nicotine use is crucial. The study emphasizes the need for targeted interventions that address both mental health and substance use, aiming to provide support for young individuals grappling with these overlapping challenges. By recognizing the link between mental health symptoms and increased nicotine consumption, stakeholders can work towards more effective prevention and treatment strategies.
September 14, 2025 - 02:22
John Abraham Discusses Lake Health at Minnesota State FairJohn Abraham, a professor of mechanical engineering, recently appeared on WCCO Radio during the Minnesota State Fair, where he engaged in a conversation with hosts Adam Carter and Jordana Green....
September 13, 2025 - 01:39
Vaccine Advisory Committee to Review Covid Shot Data Next WeekThe vaccine advisory committee is set to convene next week to evaluate and make recommendations regarding the updated Covid shots for the upcoming fall season. This meeting comes at a time when...
September 12, 2025 - 02:37
Exploring the Future of Women's Health ResearchWhile we understand more about women’s health than ever before, critical gaps remain. How can we delve deeper into the lifestyle and genetic factors that influence women`s health outcomes? As we...
September 11, 2025 - 01:12
New FDA Regulations Target Compounded GLP-1 Medications While Apple Expands Health FeaturesThe FDA has announced new regulations aimed at addressing the rising popularity of compounded GLP-1 medications, which have gained traction as effective treatments for obesity and diabetes. These...